Latest Regulatory News

Johns Lyng Group has entered a binding scheme implementation deed with Pacific Equity Partners for a $1.1 billion acquisition at $4.00 per share, representing a significant premium and a 10.3x EV/EBITDA multiple. The transaction awaits shareholder and regulatory approvals, with major shareholder backing and a clear timetable set for late 2025.

Rey Resources Limited has dispatched its Target's Statement recommending shareholders accept an unconditional $0.028 per share cash offer from Vigorous Resources Pty Ltd. The bid, which offers a significant premium over historical prices, opens on 9 July and closes on 11 August 2025.

AML3D Limited has confirmed it complied with ASX continuous disclosure rules regarding its recent Letter of Intent with the US Navy, clarifying the timing of its awareness and announcement.

Hydralyte USA has completed its Rights Issue by placing 5 million shortfall shares, raising a total of $608,878 before costs. The move finalizes the company’s recent capital raising efforts under full regulatory compliance.

Lowell Resources Fund updates its estimated FY25 dividend to AUD 0.0274 per unit with a partly franked component, alongside a revised distribution reinvestment plan price at a 10% discount.

Yowie Group has decided not to proceed with its planned takeover bid for Keybridge Capital after a key condition was triggered, signaling a strategic retreat.

Bryah Resources has lodged a formal application with the Takeovers Panel alleging breaches of takeover laws by shareholders linked to GBA Capital and Yonglu Yu, amid a looming boardroom showdown.

GTi Energy has raised $2.5 million from the first tranche of a $4.5 million placement to fund drilling at its Lo Herma uranium project, with key permits expected in August and a strategic investment from Snow Lake Energy pending shareholder approval.

Yowie Group has appointed Jesse Hamilton as its new Company Secretary, following the resignation of John Patton. The company also confirmed the automatic termination of executive roles held by former directors Nicholas Bolton and John Patton.

Peninsula Energy has locked in a $15 million debt facility from Davidson Kempner to advance commissioning at its Lance uranium project and support an upcoming equity raise. The funding aims to sustain momentum towards production resumption and ASX relisting.

Imagion Biosystems has received encouraging feedback from the FDA on its planned Phase 2 HER2 breast cancer clinical trial, paving the way for its Investigational New Drug application submission later this year.

Ausgold Limited has raised A$35 million through a well-supported placement to accelerate its Katanning Gold Project in Western Australia towards a final investment decision.